Notatki do odcinka
In a disease where hope has been scarce for decades, Belgian biotech Bioxodes is rewriting the rules of stroke treatment. Join your host Mike Ward in conversation with CEO Marc Dechamps as he reveals how his team transformed an unlikely discovery from tick saliva into BIOX-101, a first-in-class candidate therapeutic that could revolutionize care for intracerebral hemorrhage (ICH) patients. With no approved treatments available for ICH, a devastating condition that claims nearly 50% of patient...

